Results 141 to 150 of about 617,337 (267)

Graphene-Enhanced Construction Materials

Graphene, a two-dimensional nanomaterial composed of a single layer of carbon atoms arranged in a hexagonal lattice, possesses exceptional mechanical, thermal, electrical, and chemical properties. When incorporated into conventional construction materials such as concrete, cement, asphalt, coatings, and composites, graphene significantly improves ...
openaire   +3 more sources

Freestanding Polymer Metasurface Supporting Higher-Order Optical Resonances for Strong Field Enhancement in TMD Monolayers. [PDF]

Small
Deng CZ, Shi S, Chiang CH, Chen MH, Liu S, Sakurai H, Fu JH, Konishi K, Iwanaga M, Tung V, Ho YL.   +10 more
europepmc   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source

RETRACTED: Haghbin et al. Enhancement of the Electrical Conductivity and Interlaminar Shear Strength of CNT/GFRP Hierarchical Composite Using an Electrophoretic Deposition Technique. <i>Materials</i> 2017, <i>10</i>, 1120. [PDF]

Materials (Basel)
Haghbin A, Liaghat G, Hadavinia H, Arabi AM, Pol MH.   +4 more
europepmc   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Cascaded Broadband Low-Frequency Microwave Absorption Covering P- to C-Band in Ultra-Thin Metamaterials via Synergistic Local‑Field and Loss‑Field Enhancement. [PDF]

Nanomicro Lett
Yang Q, Hou H, Lu Y, Guo Z, Sun J, Zhang P, Yang T, Meng F.   +7 more
europepmc   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source

Gel-confined strain amplifies FRET efficiency toward red emission enhancement beyond pressure quenching. [PDF]

Sci Adv
Yu X, Hu H, Xie Y, Niu G, He X, Wang J, Sui L, Yuan K, Wang K, Xiao G, Wei H, Zou B.   +11 more
europepmc   +1 more source

Enhanced captured material

D2.2 will deliver the enhanced captured footage to S&M for them to again evaluate and use in their improved HDR shot pipeline.
openaire   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source